Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty ...

Headlines,Institutional investors increase their stakes in Kenvue Inc.,XML Financial LLC acquires significant position in ...

By Mariam Sunny and Bhanvi Satija (Reuters) -Neutrogena-owner Kenvue's third-quarter sales fell short of expectations on ...

Net income: US$383.0m (down 13% from 3Q 2023). Profit margin: 9.8% (down from 11% in 3Q 2023). EPS: US$0.20 (down from ...

Jefferies has recently initiated Kenvue Inc (KVUE) stock to Buy rating, as announced on September 24, 2024, according to Finviz. Earlier, on September 24, 2024, RBC Capital Mkts had reduced the stock ...

Kenvue reported third-quarter sales marginally below Wall Street estimates on Thursday, hurt by weakness in its skin health ...

Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in ...

The Neutrogena owner has named former Hydrafacial and Coty exec Stanleick as President, Skin Health & Beauty for North ...

Wall Street's expectations appear to be that the company's slower-than-average growth is going to continue over the next few years. The problem in Starboard's view is that Kenvue's skin and beauty ...

Fiera Capital Corp reduced its position in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 9.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange ...

Reports Q3 revenue $3.9B, consensus $3.93B. “During the third quarter, we continued to drive strong productivity and realize efficiency ...

Kenvue announced financial results for the fiscal third quarter which ended September 29, 2024. Net sales in Q3 reached ...